High-Resolution Cellular Mapping
Builds spatial maps of tissue architecture by identifying and locating cell types using protein expression patterns
About Our Platform
High-Resolution Cellular Mapping from Proteome Data
SpatioProteome.Ai® is a spatial proteomics platform that reconstructs tissue architecture by analyzing protein expression and cellular localization. Unlike conventional bulk or single-cell approaches, it delivers a more holistic understanding of how different cell types are organized within a tissue and how they interact over time, particularly under disease conditions or therapeutic influence.
Why Use SpatioProteome.Ai®
Bridging the Gaps in Disease Understanding
Traditional proteomics techniques often fail to capture the spatial complexity and heterogeneity of diseased tissues. SpatioProteome.Ai® addresses this limitation by mapping cell types, phenotypes, and functional states within their native environments. This spatial intelligence is critical in understanding why therapies succeed or fail, and when intervention is most effective. It also enables the discovery of prognostic and predictive biomarkers by tracking how cellular composition changes over time—making it invaluable for clinical research, translational science, and drug development.
The platform uses high-resolution imaging and proteomic data to segment individual cells and annotate them based on protein marker expression. Through this, SpatioProteome.Ai® generates spatial maps of cellular phenotypes, distribution, and interactions across tissue environments. This allows precise monitoring of cellular state changes over time and across conditions.
Key Features & Capabilities
Dynamic Disease Insight
Tracks how cell composition and functional states change across disease stages or therapeutic interventions.
Therapeutic Response Analysis
Reveals spatial signatures linked to therapy resistance, efficacy, and relapse potential.
Cell Segmentation and Phenotyping
Uses marker-based pipelines to segment cells and define their phenotypes in situ.
Biomarker Discovery
Identifies spatially localized prognostic and predictive biomarkers that are invisible in bulk analyses.
Supports Prognosis and Stratification
Enhances precision medicine by providing actionable insight into disease subtypes and progression risks.
Build the future of
biology with us
Contact Us
Stay Ahead with
ThinkBio.Ai®
Subscribe to our newsletter to receive the latest updates on products, sustainability efforts and services.